11 UK & European firms viewed as attractive investment opportunities by Goldman Sachs amid global economic uncertainty.

11 UK & European firms including GSK, Roche, ASML, Nestlé, Novartis, Novo Nordisk, L'Oreal, LVMH, AstraZeneca, SAP & Sanofi are viewed as attractive investment opportunities by Goldman Sachs, despite global economic uncertainty. These multinationals are not reliant on domestic economies, have strong growth, good balance sheets, and offer attractive dividends. They are set to benefit from lower interest rates in their home countries.

August 23, 2024
3 Articles